While this has not yet been officially
announced, The WPHA passed a resolution endorsing prescriptive access to medicinal
cannabis at their June 1999 meetings. The following is a draft of the WPHA resolution on
medical marijuana. We have not yet received a copy of the resolution as adopted at the
meetings, but have been advised it is nearly identical by WPHA representatives. - DPFWI
Access to Therapeutic
BEING AWARE that cannabis/marijuana, etc. has been used medicinally for centuries and that
cannabis projects were widely prescribed by physicians in the United States until 1937 (1
& 2); and
BEING FURTHER AWARE that the Controlled Substances Act of 1970 completely prohibited all
medicinal use of marijuana by placing it in the most restrictive category of Schedule I,
whereby drugs must meet three criteria for placement in this category: 1) have no
therapeutic value, 2) are not safe for medical use, and 3) have a high abuse potential (3)
KNOWING that 36 states have passed legislation recognizing marijuana's therapeutic value
(4 & 5); and
UNDERSTANDING that marijuana has been reported to be effective in: a) reducing intraocular
pressure in glaucoma (6), b) reducing nausea and vomiting associated with chemotherapy
(7), c) stimulating the appetite for patients living with AIDS (acquired immunodeficiency
syndrome) and suffering from the wasting syndrome (8), d) controlling spasticity
associated with spinal cord injury and multiple sclerosis (9); and
UNDERSTANDING that marijuana seems to work differently from many conventional medications
for the above problems, making it a possible option for persons resistant to conventional
medications (10); and
REALIZING that patients not helped by conventional medications and treatments may find
relief from their suffering with the use of marijuana if their primary care providers were
able to prescribe this as a treatment medication for specific diseases such as those cited
CONCLUDING that greater harm is caused by the legal consequences of its prohibition than
possible risks of medicinal use;
THEREFORE, WPHA urges the Governor of Wisconsin and the Wisconsin Legislature to move
expeditiously to make cannabis available as a legal medicine where shown to be safe and
Abel EA.Marihuana: The First Twelve Thousand Years. New York:
McGraw-Hill Book Company, 1982.
Mikuriya TH, ed. Marijuana: Medical Papers 1839-1972. Oakland,
CA: Medic-Comp Press, 1973.
Controlled Substances Act of 1970 (Pub. L. 91-513, October 27,
1970, 21USC801 et seq.).
Alliance for Cannabis Therapeutics. No accepted medical value??
ACT News. Spring, 1995;
5. Grinspoon L, Bakalar JB. Marihuana as Medicine: A plea for
reconsideration. JAMA. 1995; 273(23:1875-1876.
Colasanti BK. Review: Ocular hypotensive effect of marihuana
cannabinoids: Correlate of central action or separate phenomenon. J Ocular Pharmacol.
Sallan Se, Zinberg NE, Frei III E. Antiemetic effect of
delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy. New Engl. J. Med.
Nelson K, Walsh D, Deeter P, et al. A phase II study of
delta-9-tetrahydrocannabionol for appetite stimulation in cancer-associated anorexia. J
Palliative Care. 1994;10(1):14-18.
Clifford DB. Tetrahydrocannabinol for tremor in multiple
sclerosis. Ann Neurol. 983:13:669-671.
Mechoulam R, ed. Cannabinoids as Therapeutic Agents. Boca Raton, FL;
CRC Press, 1986.